What does the evidence say about Hop Extract Sleep Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Hop Extract Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Menopause is a critical stage of women's life associated with various complaints and distresses. [Abdi F (2016); evidence level 4] - Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. [Abdi F (2016); evidence level 4] - The results correlated with the metabolism data and showed that hop extract and 6-PN preferentially enhanced P450 1A1 mRNA expression and increased P450 1A1/1B1 activity. [Wang S (2016); evidence level 4] - 6-PN was found to be an AhR agonist that significantly induced XRE activation and inhibited 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced XRE activity. [Wang S (2016); evidence level 4] - (hops) is a popular botanical dietary supplement used by women as a sleep aid and for postmenopausal symptom relief. [Wang S (2016); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.